Description
Clinical Description
BioRePeelCl3® FND is a professional biphasic chemical peel developed by CMed Aesthetics for facial skin rejuvenation and exfoliation. The formulation combines trichloroacetic acid (TCA), alpha-hydroxy acids (AHAs), beta-hydroxy acids (BHAs), amino acids, vitamins, and GABA within a patented two-phase technology designed to promote controlled exfoliation while supporting skin revitalisation.
Unlike traditional high-downtime chemical peels, BioRePeelCl3 FND is formulated to provide exfoliating and keratolytic effects while helping maintain skin hydration through its lipophilic and hydrophilic phases. The treatment is commonly used by aesthetic practitioners for photoaged skin, uneven skin texture, enlarged pores, acne-prone skin, and pigmentation concerns.
BioRePeelCl3 FND is intended exclusively for professional use and is supplied in sterile single-use vials. The FND version is specifically formulated for facial applications, whereas the BODY formulation is intended for larger treatment areas.
What BioRePeelCl3 FND Is Similar To
BioRePeelCl3 FND belongs to the category of professional chemical peels and may be compared with other medium-depth rejuvenation systems such as PRX-T33® and traditional TCA-based peeling formulations.
Like PRX-T33®, BioRePeelCl3 combines TCA with supporting ingredients designed to improve skin appearance while minimising visible downtime. Both products are used for skin revitalisation, texture improvement, and management of photoageing concerns. However, BioRePeelCl3 incorporates a broader combination of amino acids, vitamins, AHAs, and BHAs within a patented biphasic system.
Compared with conventional TCA peels, BioRePeelCl3 is formulated to provide exfoliation alongside ingredients intended to support skin conditioning and hydration. Treatment protocols and clinical outcomes may vary according to practitioner assessment and patient presentation.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to manufacturer information, BioRePeelCl3 FND may be used for:
- Facial skin rejuvenation
- Photoaged skin
- Fine lines and superficial wrinkles
- Enlarged pores
- Acne-prone skin
- Oily skin
- Hyperpigmentation and uneven skin tone
- Textural irregularities
Treatment Area:
- Face (FND formulation)
Usage / Administration (IFU-Only Section)
Administration Route: Topical professional chemical peel application.
Professional-use disclaimer: BioRePeelCl3 FND is intended for application only by appropriately trained healthcare or aesthetic professionals according to manufacturer instructions and aseptic professional standards.
Important: Specific protocol details regarding application duration, number of layers, treatment intervals, and post-treatment care should be verified directly from the manufacturer’s official instructions for use (IFU).
Ingredient List
Manufacturer information identifies the following key ingredients:
Active Components
- Trichloroacetic Acid (TCA) 35%
- Lactobionic Acid
- Salicylic Acid
- Tartaric Acid
- Citric Acid
Amino Acids
- Glycine
- Proline
- Hydroxyproline
- Arginine
Vitamins
- Riboflavin (Vitamin B2)
Additional Components
- GABA (Gamma-Aminobutyric Acid)
- Squalane
- Isopropyl Myristate
Presentation & Longevity
Presentation
- 5 x 6ml sterile single-use vials
- Professional clinic-use packaging
Shelf Life
Not provided by manufacturer.
Longevity
Treatment duration and longevity are not specified by the manufacturer. Clinical outcomes vary according to patient characteristics, treatment protocol, skincare routine, and practitioner assessment.
Safety Notes / Contraindications
According to available manufacturer documentation and standard chemical peel precautions:
- Contraindicated in patients with known hypersensitivity to any component.
- Avoid treatment on skin affected by active infection, inflammation, or open wounds.
- Use caution in patients with compromised skin barrier function.
- Avoid use during periods of significant skin irritation or active dermatological disease unless specifically advised by a healthcare professional.
Post-procedure sun protection and practitioner-directed aftercare are recommended following treatment.
Regulatory Status
BioRePeelCl3 FND is marketed within the European aesthetic medicine sector and is distributed as a professional-use chemical peeling product.
CE Marking: Reported by manufacturer and authorised distributors.
UKCA Status: Verify via manufacturer or authorised distributor.
FDA Status: Not identified in publicly available documentation reviewed.
FAQ
1. What is BioRePeelCl3 FND?
BioRePeelCl3 FND is a professional biphasic TCA chemical peel formulated for facial rejuvenation and exfoliation. It combines 35% trichloroacetic acid with amino acids, vitamins, and supporting ingredients designed to improve skin texture and appearance while maintaining patient comfort during treatment.
2. What skin concerns can BioRePeelCl3 FND address?
According to manufacturer information, BioRePeelCl3 FND may be used for photoageing, uneven skin texture, enlarged pores, acne-prone skin, superficial pigmentation concerns, and overall skin revitalisation. Suitability should always be determined through professional consultation and assessment.
3. Is BioRePeelCl3 FND the same as a traditional TCA peel?
BioRePeelCl3 contains 35% TCA but differs from traditional TCA peels because it incorporates amino acids, vitamins, GABA, and a biphasic delivery system. The formulation is designed to provide exfoliation alongside skin-conditioning support.
4. How is BioRePeelCl3 FND administered?
BioRePeelCl3 FND is applied topically by qualified professionals. Specific treatment protocols, application times, number of layers, and treatment intervals should be verified directly from the official manufacturer IFU because these details are not consistently disclosed in publicly available documentation.
5. What is the difference between BioRePeelCl3 FND and BioRePeelCl3 BODY?
The FND formulation is intended primarily for facial treatments, while BioRePeelCl3 BODY is designed for larger body areas. Although both utilise the BioRePeel biphasic technology, treatment indications and application areas differ according to manufacturer guidance.
